46th Annual Course on Renal Disease & Electrolyte Disorders
46th Annual Course on Renal Disease & Electrolyte Disorders is organized by University of Colorado School of Medicine - The Division of Renal Diseases and Hypertension and will be held from Jul 22 - 26, 2019 at The Gant, Aspen, Colorado, United States of America.
The University of Colorado School of Medicine designates this live activity for a maximum of 20.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This forty-sixth annual course is designed to provide the practitioner with state-of-the-art information regarding the pathogenesis and treatment of a variety of disease states. Recognized guest lecturers and members of our own faculty will give sharply focused clinically oriented talks on a range of topics.
Upon completion of the course participants should be able to:
• Review current concepts regarding the approach to mineral bone disease and the treatment of secondary hyperparathyroidism in patients with CKD or ESRD.
• Discuss various aspects of the interrelationships between kidney disease and pregnancy including the pathogenesis and treatment of preeclampsia; the pregnant patient with CKD or ESRD, nephrolithiasis or UTIs, or glomerulonephritis; and pregnancy in the kidney transplant donor or recipient.
• Outline new insights into the pathogenesis of diabetic nephropathy, the role of SGLT2 inhibitors in the treatment of diabetes and the role of kidney biopsy in the management of the diabetic patient with evidence of kidney disease.
• Describe the nature of disparities in access to kidney transplantation, the feasibility of kidney transplantation in patients with HCV or HIV infection, and the nature of the recurrent glomerular disease in the kidney transplant recipient.
• Summarize the results of key literature articles of the past year in the areas of CKD and dialysis, glomerulonephritis, and transplantation and be prepared to implement this knowledge in clinical practice.
|Contact No. :||3037244852
|Registration Type||Due Date||Price|
|Standard Registration Conference Fee||22 Jul,2019||USD 775.00|
|Residents/Fellows Conference Fee||22 Jul,2019||USD 450.00|
|Registration Type||End Date||Price|
|Standard Registration Early Fee||31 May,2019||USD 725.00|
|Residents/Fellows Early Fee||31 May,2019||USD 400.00|